Strong Progress and Financial Update from Celldex Therapeutics
August 8, 2025 - 01:36
Celldex Therapeutics has announced significant advancements in its pipeline, showcasing impressive results from its Phase 2 CSU study. The data revealed a profound and sustained complete response in patients, along with an improved quality of life measured seven months after the conclusion of barzolvolimab dosing. This breakthrough underscores the company's commitment to developing innovative therapies.
In addition to the CSU study results, Celldex is anticipating further data from ongoing Phase 2 studies of barzolvolimab targeting eosinophilic esophagitis (EoE) and chronic inducible urticaria (CIndU). Furthermore, results from a Phase 1 study of CDX-622 in healthy volunteers are expected in the latter half of 2025. These upcoming data releases are highly anticipated by stakeholders and could have significant implications for the company’s future direction and product offerings.
The financial results reported for the second quarter of 2025 reflect the company's strong execution and strategic focus on advancing its clinical programs, positioning it well for continued growth in the biopharmaceutical landscape.
MORE NEWS
June 8, 2026 - 04:51
Is PDD Holdings Inc. (PDD) A Good Stock To Buy Now?A recent discussion on a value investing forum laid out a bullish case for PDD Holdings Inc., the parent company of e-commerce platforms Temu and Pinduoduo. As of late May, shares were trading near...
June 7, 2026 - 03:13
Apple Stock: Buy, Sell, or Hold?Apple`s stock is trading close to an all-time high, and a series of potential catalysts could sustain the upward momentum. The company continues to benefit from strong demand for its latest iPhone...
June 6, 2026 - 22:38
Eli Lilly's $3.8 Billion Vaccine Bets: Here's the Big Story Many Investors Are MissingEli Lilly is making a serious push into the vaccine business. The pharmaceutical giant announced a trio of acquisitions totaling $3.8 billion, aimed at building a new division focused on infectious...
June 6, 2026 - 12:16
Are US Treasuries becoming a financial chokepoint?For decades, US government bonds were the bedrock of global finance. Investors bought them during crises, banks used them as collateral, and central banks held them as reserves. But a growing...